Corteva Inc
CTVA: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$12.00 | Bqn | Jfxhcwqm |
Corteva Earnings: Inventory Reset Weighs on Crop Protection Profits
Corteva's detailed third-quarter results confirm our initial view that the company is likely to face a continued profit decline in 2023 due to an industrywide crop chemicals inventory reset. The company had released preliminary revised earnings expectations in late October. With our outlook unchanged, we maintain our $67 fair value estimate and wide moat rating.